37.0 D-
Dihexa
Also known as: PNB-0408, N-hexanoic-Tyr-Ile-(6) aminohexanoic amide
Preclinical Only Research Chemical
Research Evidence 9.0/100
Safety Profile 65.0/100
0 Clinical Trials
No clinical trials registered for this peptide.
17 Research Papers
- Localization of alveolar surfactant clearance in rabbit lung cells. Am J Physiol unknown
- Small-Molecule-Directed Hepatocyte-Like Cell Differentiation of Human Pluripotent Stem Cells. Curr Protoc Stem Cell Biol unknown
- The Brain Hepatocyte Growth Factor/c-Met Receptor System: A New Target for the Treatment of Alzheimer's Disease. J Alzheimers Dis Review
- The development of small molecule angiotensin IV analogs to treat Alzheimer's and Parkinson's diseases. Prog Neurobiol Review
- Dimeric DOTA-alpha-melanocyte-stimulating hormone analogs: synthesis and in vivo characteristics of radiopeptides with high in vitro activity. J Recept Signal Transduct Res unknown
Showing 5 of 17 papers by citation count.
FDA Data
Not FDA-Approved
Dihexa has not been evaluated by the FDA for safety or efficacy. It is not approved for human therapeutic use in the United States.
Frequently Asked Questions
Is Dihexa FDA approved?
No, Dihexa has not been approved by the FDA for human therapeutic use. It is sold as a research chemical.
What is the trust score for Dihexa?
Dihexa has a CheckPeptides trust score of 37.0/100 (grade: D-). This score is based on clinical trial volume, research paper quality, FDA data, and evidence classification.
Last verified: April 7, 2026
Quick Facts
- Classification
- HGF/MET signalling enhancer
- Molecular Weight
- 504.7 Da
- PubChem
- CID 129010512 ↗
- Regulatory Status
- N/A
Score Breakdown
Research Evidence 9.0/100
Safety Profile 65.0/100
Evidence Summary
- Clinical Trials
- 0
- Research Papers
- 17
- Trust Score
- 37.0/100
- Grade
- D-